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A B S T R A C T
Background
Peripheral arterial disease (PAD) of the lower limb is common, with prevalence of both symptomatic and asymptomatic disease estimated
at 13% in the over 50 age group. Symptomatic PAD affects about 5% of individuals in Western populations between the ages of 55
and 74 years. The most common initial symptom of PAD is muscle pain on exercise that is relieved by rest and is attributed to reduced
lower limb blood flow due to atherosclerotic disease (intermittent claudication). The ankle brachial index (ABI) is widely used by a
variety of healthcare professionals, including specialist nurses, physicians, surgeons and podiatrists working in primary and secondary
care settings, to assess signs and symptoms of PAD. As the ABI test is non-invasive and inexpensive and is in widespread clinical use, a
systematic review of its diagnostic accuracy in people presenting with leg pain suggestive of PAD is highly relevant to routine clinical
practice.
Objectives
To estimate the diagnostic accuracy of the ankle brachial index (ABI) - also known as the ankle brachial pressure index (ABPI) - for the
diagnosis of peripheral arterial disease in people who experience leg pain on walking that is alleviated by rest.
Search methods
We carried out searches of the following databases in August 2013: MEDLINE (Ovid SP),Embase (Ovid SP), the Cumulative Index
to Nursing and Allied Health Literature (CINAHL) (EBSCO), Latin American and Caribbean Health Sciences (LILACS) (Bireme),
Database of Abstracts of Reviews of Effects and the Health Technology Assessment Database in The Cochrane Library, the Institute
for Scientific Information (ISI) Conference Proceedings Citation Index - Science, the British Library Zetoc Conference search and
Medion.
Selection criteria
We included cross-sectional studies of ABI in which duplex ultrasonography or angiography was used as the reference standard. We
also included cross-sectional or diagnostic test accuracy (DTA) cohort studies consisting of both prospective and retrospective studies.
Participants were adults presenting with leg pain on walking that was relieved by rest, who were tested in primary care settings or
secondary care settings (hospital outpatients only) and who did not have signs or symptoms of critical limb ischaemia (rest pain,
ischaemic ulcers or gangrene).
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The index test was ABI, also called the ankle brachial pressure index (ABPI) or the Ankle Arm Index (AAI), which was performed with
a hand-held doppler or oscillometry device to detect ankle vessels. We included data collected via sphygmomanometers (both manual
and aneroid) and digital equipment.
Data collection and analysis
Two review authors independently replicated data extraction by using a standard form,which included an assessment of study quality, and
resolved disagreements by discussion. Two review authors extracted participant-level data when available to populate 2×2 contingency
tables (true positives, true negatives, false positives and false negatives).
After a pilot phase involving two review authors working independently, we used themethodological quality assessment tool theQuality
Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2), which incorporated our review question - along with a flow diagram to
aid reviewers’ understanding of the conduct of the study when necessary and an assessment of risk of bias and applicability judgements.
Main results
We screened 17,055 records identified through searches of databases. We obtained 746 full-text articles and assessed them for relevance.
We scrutinised 49 studies to establish their eligibility for inclusion in the review and excluded 48, primarily because participants were
not patients presenting solely with exertional leg pain, investigators used no reference standard or investigators used neither angiography
nor duplex ultrasonography as the reference standard. We excluded most studies for more than one reason.
Only one study met the eligibility criteria and provided limb-level accuracy data from just 85 participants (158 legs). This prospective
study compared the manual doppler method of obtaining an ABI (performed by untrained personnel) with the automated oscillometric
method. Limb-level data, as reported by the study, indicated that the accuracy of the ABI in detecting significant arterial disease on
angiography is superior when stenosis is present in the femoropopliteal vessels, with sensitivity of 97% (95% confidence interval (CI)
93% to 99%) and specificity of 89% (95% CI 67% to 95%) for oscillometric ABI, and sensitivity of 95% (95% CI 89% to 97%)
and specificity of 56% (95% CI 33% to 70%) for doppler ABI. The ABI threshold was not reported. Investigators attributed the
lower specificity for doppler to the fact that a tibial or dorsalis pedis pulse could not be detected by doppler in 12 of 27 legs with
normal vessels or non-significant lesions. The superiority of the oscillometric (automated) method for obtaining an ABI reading over
the manual method with a doppler probe used by inexperienced operators may be a clinically important finding.
Authors’ conclusions
Evidence about the accuracy of the ankle brachial index for the diagnosis of PAD in people with leg pain on exercise that is alleviated
by rest is sparse. The single study included in our review provided only limb-level data from a few participants. Well-designed cross-
sectional studies are required to evaluate the accuracy of ABI in patients presenting with early symptoms of peripheral arterial disease
in all healthcare settings. Another systematic review of existing studies assessing the use of ABI in alternative patient groups, including
asymptomatic, high-risk patients, is required.
P L A I N L A N G U A G E S U M M A R Y
Ankle brachial index for the diagnosis of lower limb peripheral arterial disease
Peripheral arterial disease (PAD) of the legs affects 13% of people over 50 years of age. Sometimes PAD is “silent” and people are
unaware they have it, but PAD can cause pain in the legs, especially with walking, and this type of symptomatic PAD affects about 5%
of people in the Western world between the ages of 55 and 74 years. In PAD, fatty deposits (atherosclerosis) and blood clots cause the
arteries to narrow and block. This leads to poor blood flow to the muscles during exercise, causing the classical symptom of muscle
pain during walking that goes away after rest (intermittent claudication). In severe cases of PAD, symptoms of rest pain, ulceration and
gangrene may develop and, if untreated, can lead to lower limb amputation. People with PAD are also at higher risk for cardiovascular
disease and stroke.
The ankle brachial index (ABI) is a test that is used to facilitate diagnosis of PAD. This test uses a device for measuring blood pressure
with an inflatable cuff, and blood pressure measurements are taken at the upper arm and the ankle. The equipment can be manual
or digital with automatic electronic calculation of blood pressure. The ABI is widely used for assessment of PAD by specialist nurses,
physicians, surgeons and podiatrists working in hospitals. Dividing blood pressure recorded at the ankle by that recorded at the arm
produces a ratio. Ratios of 0.90 to 1.30 are considered normal for adults, and ratios less than 0.8 indicate that PAD is present. Lower
readings (< 0.7) suggest that the disease is severe and people might develop ulcers and gangrene. People with mild to moderate PAD can
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arrive at a diagnosis by several routes when using the ABI: during routine diabetic foot checks in general practice, in community health
clinic or hospital settings, as a screening test for PAD in people who have no symptoms and during assessment of people presenting with
exertional leg pain suggestive of PAD. Once a diagnosis of PAD is established, treatment will include prescribed secondary prevention
therapy and lifestyle advice (exercise, smoking cessation, diet, weight), and for those with impaired quality of life, treatment may include
supervised exercise therapy, or revascularisation, which commonly involves endovascular treatment rather than surgery.
In hospitals, other tests may be used to diagnose PAD. Duplex ultrasound (DUS) shows blood flow in the arteries and is non-invasive,
but only an experienced radiologist can achieve useful images. Hospital staff can use other tests to image the blood vessels, namely,
computerised tomography angiography (CTA), magnetic resonance angiography (MRA) and catheter angiography.
The ABI test is non-invasive and inexpensive and is widely used clinically; therefore, we have reviewed all available reports obtained from
a wide search of databases of medical literature to estimate its accuracy in identifying PAD in people who experience pain on walking
that goes away after rest. Two review authors independently assessed studies that met inclusion criteria of the review, including use of a
cross-sectional study design; enrolment of participants with pain on walking that got better with rest; and use of duplex ultrasonography
or angiography to check that results of the ABI test were accurate. One study met our criteria and provided data from 85 participants
(158 limbs). Investigators compared the manual doppler method of measuring ABI with the automated method. Researchers provided
only data for legs as opposed to data for patients; we were therefore unable to recalculate the analysis at the whole-participant level.
In conclusion, we found little evidence about the accuracy of the ankle brachial index for diagnosing PAD in people presenting with
exertional leg pain. The study included in our review had some flaws, and well-designed cross-sectional studies are needed to measure
the accuracy of the ABI for diagnosing PAD in patients with early symptoms.
B A C K G R O U N D
Peripheral arterial disease (PAD) of the lower limbs is common,
with prevalence of both symptomatic and asymptomatic disease
estimated at 13% in the over 50 age group (Hirsch 2001). Symp-
tomatic PAD affects about 5% of individuals in Western popula-
tions between the ages of 55 and 74 years (Khan 2007). The most
common initial symptom of PAD is muscle pain on exercise that
is relieved by rest and is attributed to reduced lower limb blood
flow due to atherosclerotic disease (intermittent claudication; IC).
Patients with more severe PAD may develop rest pain, ulceration
and gangrene (critical limb ischaemia; CLI), which, if untreated,
can lead to lower limb amputation (Hooi 2007; Twine 2009). The
presence of PAD has been shown to be a marker of underlying
cardiovascular disease.
A simple, non-invasive test known as the ankle brachial index
(ABI) - or the ankle brachial pressure index (ABPI) - can de-
tect PAD. Healthcare providers can use the ABI to screen asymp-
tomatic patients at increased risk of developing PAD, for exam-
ple, people with diabetes, and to assess people presenting with leg
pain suggestive of PAD. Clinicians can use a low ABI, even in
the absence of symptoms, to identify people who are at increased
risk of cardiac and cerebrovascular disease (Ankle Brachial Index
Collaboration 2008; SIGN 2007).
Dividing the highest ankle pressure (obtained in the posterior
tibial, dorsalis pedis and, when required, peroneal arteries) by
the highest systolic arm pressure yields the ABI ratio. Classically,
healthcare providers have used a doppler probe to detect signals
within the arteries, but recently designed oscillometric and pho-
tophlethysmographic devices are now available. Current guide-
lines do not endorse the use of these newer devices but recommend
the hand-held doppler technique (NICE 2012). Ratios of 0.90 to
1.30 are normal for adults, ratios less than 0.9 are indicative of
arterial stenosis and ratios less than 0.5 are associated with CLI
(Bhasin 2007; MacLeod-Roberts 1995; NICE 2012). Individuals
with aorto-iliac disease may have normal ABI at rest and low val-
ues after exercise. An ’exercise-ABI’ test can detect this and can be
performed during secondary care.
A wide variety of healthcare professionals, including specialist
nurses, physicians, surgeons and podiatrists working in primary
and secondary care settings, frequently use the ABI to assess PAD.
These providers normally check foot and leg pulses of people pre-
senting with leg pain suggestive of PAD before performing an
ABI to determine their presence or absence. Once PAD is diag-
nosed, first-line management of the condition consists of cardiac
risk factor management, which includes lifestyle advice, smok-
ing cessation, statin and antiplatelet therapy, blood pressure con-
trol and screening for and treatment of diabetes (Bhasin 2007;
Heald 2006). Supervised exercise programmes can lead to symp-
tomatic improvement, and healthcare providers can perform arte-
rial revascularisation, in the form of angioplasty or less commonly
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surgery, to treat those with incapacitating disease and significantly
impaired quality of life (Cassar 2003; Chang 2011; de Backer
2012; Fokkenrood 2013; Lane 2014; NICE 2012; Rutherford
1997). Physicians may prescribe naftidrofuryl oxalate for patients
in whom supervised exercise therapy has not been found to be
effective and who do not wish to be referred for revascularisation
(NICE 2012).
In secondary care, hospital staff may use a variety of non-invasive
imaging tests for patients with suspected PAD in whom revascu-
larisation may be considered, including non-invasive duplex ul-
trasonography, computerised tomography angiography (CTA) or
magnetic resonance angiography (MRA). The National Institute
for Health and Care Excellence suggests duplex ultrasonography
as the first-line approach for imaging PAD, and CTA or contrast-
enhancedMRA for those whoneed further imaging (NICE 2012).
The ABI test is non-invasive and inexpensive and is in widespread
clinical use; a systematic review of its diagnostic accuracy in people
presenting with leg pain suggestive of PAD is highly relevant to
routine clinical practice.
Target condition being diagnosed
Presence or absence of peripheral arterial disease of the lower limb.
Index test(s)
Healthcare providers use the ankle brachial index (ABI) to diag-
nose peripheral arterial disease (PAD), by dividing highest sys-
tolic pressure measured in the arteries at the ankle (dorsalis pedis
and posterior tibial arteries, or peroneal if the others are non-de-
tectable) by highest systolic blood pressure at the arm (brachial
artery).
Physicians can calculate an ankle brachial ratio in several ways.
UK clinical guidelines recommend that the patient is rested in a
supine position and that blood pressure is taken by using a sphyg-
momanometer with an appropriately sized cuff at the brachial
artery and the posterior tibial, dorsalis pedis and, when possible,
peroneal arteries. A doppler probe detects audible systolic pressure
(Aboyans 2012; McDermott 2000; NICE 2012).
For each leg, the healthcare professional calculates the ABI by
dividing the highest ankle pressure by the highest pressure reading
taken from the arm (McDermott 2000). MacLeod-Roberts 1995
presents a classification of ABI values.
In this review, we use the threshold of less than 0.90 to distin-
guish between positive (< 0.90) and negative (≥ 0.90) test results.
Clinicians commonly use this threshold in clinical practice, and is
cited in current guidelines (NICE 2012).
The position of the patient at the time blood pressure is taken is
important: For each inch that the ankle is positioned below the
heart, care providers have noted a 1 mmHg increase in systolic
ankle blood pressure (MacLeod-Roberts 1995).
False negatives commonly occur in people who have calcification
of the ankle artery wall, which creates incompressibility and an
artificially high reading. This may occur in some patients with
diabetes (Bhasin 2007; MacLeod-Roberts 1995).
Several automated blood pressure machines are available, and all
are eligible for inclusion in the review.
Clinical pathway
Healthcare providers may follow several clinical pathways to diag-
nose mild to moderate PAD by using the ABI: They may measure
the ABI in primary care to diagnose PAD in members of the gen-
eral population who report symptoms of exertional leg pain. They
sometimes use ABI in addition to routine diabetic foot checks in
primary care, community health settings or hospital settings as a
screening test for PAD in people who have no symptoms but are at
high risk. Once a diagnosis of PAD is established, healthcare staff
will prescribe secondary prevention therapy and will give lifestyle
advice (exercise, smoking cessation, diet, weight); for those who
have impaired quality of life, they may offer supervised exercise
therapy, or revascularisation, which commonly involves endovas-
cular treatment rather than surgery.
Role of index test(s)
Practitioners use the ABI test in healthcare settings to identify
PAD in people who have suggestive symptoms, and can use this
test to screen those at increased risk for PAD. An ABI < 0.90
is predictive of increased risk of cardiovascular disease (Ankle
Brachial Index Collaboration 2008). This review aimed to include
studies evaluating the diagnostic test accuracy of the ABI used in
primary and secondary (outpatient only) care settings by a range
of healthcare professionals, to evaluate people presenting with leg
pain on exercise that is relieved by rest, which is suggestive of
underlying PAD.
Alternative test(s)
Uses of the ABI in clinical practice are diverse, and care providers
do not need to consider standard alternative tests.
Rationale
The success of management strategies for PAD depends upon the
quality of the diagnostic process, which involves careful assessment
of underlying pathology through diagnostic tests that possess a
high level of accuracy.
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O B J E C T I V E S
To estimate the diagnostic accuracy of the ankle brachial index
(ABI) - also known as the ankle brachial pressure index (ABPI)
- for the diagnosis of peripheral arterial disease in people who
experience leg pain on walking that is alleviated by rest.
Secondary objectives
We also intended to investigate the effect of sources of hetero-
geneity on diagnostic accuracy, specifically, study setting, previous
tests, types of equipment used, types of reference standards ap-
plied, different groups of patients examined (people with type 1 or
type 2 diabetes and suspected aorto-iliac disease) and duration of
symptoms, by including them as co-variates in the meta-analysis,
if sufficient studies provided relevant data. It was our intention
that we would examine graphically other potential sources of het-
erogeneity for signs that they were a cause of heterogeneity.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included studies of ABI that used duplex ultrasonography or
angiography as the reference standard.We included cross-sectional
or diagnostic test accuracy (DTA) cohort studies examining both
prospective and retrospective studies. These studies had to report
that all participants received a reference standard; investigators had
to present cross-tabulated results of the index test and the reference
standard (2×2 table), or had to report sufficient information to
allow the 2×2 table data to be back-calculated.
Participants
Adults with leg pain on walking relieved by rest, who are tested
in primary care settings or secondary care settings (hospital out-
patients only) and do not have signs or symptoms of critical limb
ischaemia (rest pain, ischaemic ulcers or gangrene). We excluded
from the review patients who were free of exertional leg pain, as
well as those with CLI.
Index tests
Ankle brachial index (ABI), also called ankle brachial pressure
index (ABPI).We includeddata collected by sphygmomanometers
(both manual and aneroid) as well as by digital equipment that
usedmanual or automatic inflation. We included studies that used
hand-held doppler or oscillometry to detect ankle vessels.
Target conditions
Peripheral arterial disease of the lower limbs.
Reference standards
We included studies that used duplex ultrasonography or angiog-
raphy as the reference standard test, and we noted instances in
which different reference standards were used to verify the pres-
ence or absence of disease in the same study population.
Search methods for identification of studies
Weapplied no restrictions in terms of date, language of publication
or publication status of studies. We used no diagnostic method
search filters.
Electronic searches
We applied no restrictions in terms of language of publication or
publication status.
We searched the following databases.
• MEDLINE Ovid (1946 to July week 5 2013).
• Embase (Ovid SP) (1980 to 2013 week 32).
• Cumulative Index to Nursing and Allied Health Literature
(CINAHL) via EBSCO (12 August 2013).
• Latin American and Caribbean Health Sciences (LILACS)
(Bireme) (13 August 2013).
• Database of Abstracts of Reviews of Effects (DARE) and
the Health Technology Assessment Database (HTA), in The
Cochrane Library (2013, Issue 7).
• Institute for Scientific Information (ISI) Conference
Proceedings Citation Index - Science (14 August 2013).
• British Library Zetoc Conference search (29 August 2013).
We used the search strategies shown in Appendix 1; Appendix 2;
Appendix 3; Appendix 4; Appendix 5; Appendix 6 and Appendix
7.
We also searchedMEDION (www.mediondatabase.nl/) using the
’Systematic Reviews of Diagnostic Studies’ search filter (29 August
2013) (Appendix 8).
Searching other resources
We reviewed the bibliographies of review articles identified by
searches for potentially relevant studies.
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Data collection and analysis
Selection of studies
One review author (FC) screened titles and abstracts retrieved by
the electronic searches, and a second review author (AA) checked
a random sample of 10% of the studies. We obtained full papers
for potentially eligible studies, including those identified by non-
electronic means. Two review authors (FC, AA) independently
applied exclusion criteria to the full papers and resolved disagree-
ments by discussion. We used a flow diagram to show results of
the decision-making process.
Data extraction and management
Two review authors (FC, AA) independently used a standard form
to replicate data extraction; this form included an assessment of
study quality. Review authors corroborated their data extraction
and quality assessment decisions and resolved disagreements by
discussion. Review authors intended to extract participant-level
data to populate 2×2 contingency tables - true positives (TPs), true
negatives (TNs), false positives (FPs) and false negatives (FNs)) -
as reported. We also extracted details of test threshold(s) used for
interpretation of results.
We collected data on mortality, adverse events, the nature of the
equipment used (manual or automated) and the number of tech-
nical failures.
Assessment of methodological quality
After a pilot phase involving two review authors working indepen-
dently, we used the Quality Assessment of Diagnostic Accuracy
Studies-2 (QUADAS-2) (Whiting 2011), which incorporated our
review question, a flow diagram to aid reviewers’ understanding
of the conduct of the study when necessary and an assessment of
risk of bias and applicability judgements. We presented review-
specific signalling questions and appropriate items concerning the
applicability of primary studies relative to the review, together with
guidance about ratings, in Appendix 9.We resolved disagreements
by discussion.
Statistical analysis and data synthesis
We intended to use 2×2 contingency tables populated with par-
ticipant-level data, rather than data on limbs, to estimate sensitiv-
ity and specificity for each study. When data were adequate, we
intended to perform a bivariate random-effects meta-analysis of
sensitivity and specificity. We anticipated that we would use these
estimates to create receiver operating characteristic (ROC) and
forest plots. As an ABI less than 0.90 is the accepted threshold used
in clinical practice, we had planned to restrict the meta-analysis to
studies that used this threshold, so that our estimates of sensitivity
and specificity would be derived directly from that threshold. We
intended to add items investigated for heterogeneity as co-variates
to the bivariate model.
However, available data are based on limbs as the unit of analysis.
If two datapoints were obtained from the same participant (one
from each leg), these datapoints will tend to be more similar to
each other than datapoints from different patients, thus changing
the variance in data. However, estimating within-study variance is
a key part of meta-analysis, and current methods do not allow for
studies in which a participant may contribute data frommore than
one potential disease site. If studies do not provide participant-
level data, we have no correct way to estimate within-study vari-
ance, and so meta-analysis, whether bivariate or based on hierar-
chical summary receiver operating characteristic (HSROC) mod-
els (Harbord 2007), or univariate meta-analysis for sensitivity and
specificity, is not an option.
We intended to perform all analyses in R 7.1 (cran.r-project.org)
and SAS 9.3 (www.sas.com).
Investigations of heterogeneity
Our planned investigations into the effect of sources of hetero-
geneity on diagnostic accuracy focussed on patient groups (e.g.
type 1 and type 2 diabetes, suspected aorto-iliac disease), duration
of symptoms, previous tests and types of equipment (automatic
or manual) by including them as co-variates in the meta-analyses.
We intended to examine other potential sources of heterogeneity
graphically for signs that they were the source of heterogeneity.
We planned to group estimates in plots according to items con-
sidered potential sources of heterogeneity, as detailed above, and
to present these as forest and ROC plots for visual assessment of
heterogeneity.
If we found sufficient studies, we planned to investigate hetero-
geneity by adding items as co-variates to the meta-analysis model,
from a bivariate or univariate analysis, depending on results of the
main analysis. However, we recognised the likelihood of having
too few studies to perform meta-regression with all items listed as
potential sources of heterogeneity, and under these circumstances,
we planned to limit ourselves to visual inspection of ROC and
forest plots.We understand that some items are investigated better
with individual participant data, as they are patient-specific, rather
than study-specific, for example, duration of symptoms, and we
planned to interpret any aggregate results cautiously.
Sensitivity analyses
We intended to conduct several sensitivity analyses to compare the
diagnostic accuracy of ABI in those with and without diabetes, in
those with and without coronary heart disease, in smokers versus
non smokers and when manual versus automated methods are
used to measure the ABI.
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Assessment of reporting bias
Methods for dealing with publication bias in reviews of diagnos-
tic accuracy studies are relatively underdeveloped. Consequently,
we interpreted our results cautiously, and with awareness of the
likelihood of publication bias, rather than by using funnel plots,
which can be challenging to interpret in this context. We planned
to consider using a funnel plot of the log of the diagnostic odds ra-
tio (lnDOR), provided we found low heterogeneity in the lnDOR
(Deeks 2005).
R E S U L T S
Results of the search
See Figure 1.
Figure 1. Study flow diagram.
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We screened 17,055 records identified through searches of
databases. We obtained and assessed for relevance 746 full-text ar-
ticles. A second review author (AA) checked a 10% random sam-
ple of these articles and reached 100% agreement with the first
review author (FC). We scrutinised 49 studies to establish their
eligibility for inclusion in the review.
We included only one study (Vega 2011) with a total of 85 par-
ticipants and have described it in the Characteristics of included
studies table.
We have listed the 48 studies excluded from the review, along with
reasons for exclusion, in the Characteristics of excluded studies
table.We excluded studies primarily because participants were not
patients presenting solely with exertional leg pain, investigators
used no reference standard or the reference standard used was nei-
ther angiography nor duplex ultrasonography. We have provided
more than one reason for exclusion of most studies.
Methodological quality of included studies
See Figure 2; Figure 3.
Figure 2. Risk of bias and applicability concerns graph: review authors’ judgements about each domain
presented as percentages across included studies.
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Figure 3. Risk of bias and applicability concerns summary: review authors’ judgements about each domain
for each included study.
The Characteristics of included studies table incorporates the
methodological quality assessment. In Vega 2011, the risk of bias
was generally ’low’, but some items had ’unclear’ risk of bias;
we explain these below. QUADAS-2 quality assessment items are
grouped into four domains: patient selection, index test, reference
standard and flow and timing.
The risk of bias arising from patient selection was unclear (Vega
2011). Although a consecutive sample of patients was reported,
inappropriate exclusions may not have been avoided. Investiga-
tors included patients who had ’suspected advanced PAD’; conse-
quently, the patient population may have been affected by disease
spectrum bias.
Investigators described the execution of ABI tests well but did not
state the ABI threshold used (Vega 2011); this led to a classification
of “unclear risk of bias”.
Vega 2011 did not report the time between ABI and angiography
assessments, which might have led to misclassification due to pro-
gression of the disease to a more advanced state (disease progres-
sion bias).
We have presented in the Characteristics of included studies table
details of the execution of index and reference standard tests used
by Vega 2011.
Findings
The one included study (Vega 2011) did not report accuracy data
at the participant level; therefore, we were unable to calculate esti-
mates of sensitivity or specificity for individual participants. The
accuracy estimates reported in the narrative synthesis below are
those calculated and reported by Vega 2011. See also Summary of
findings.
Vega 2011
This prospective study compared the manual doppler method of
obtaining an ABI with the automated oscillometric method (Vega
2011). In total, researchers recruited into the study 85 patients (76
men and nine women) with a mean (standard deviation) age of
68 (11) years, who were referred for angiography with ’symptoms
of intermittent claudication’. Study participants had several co-
morbidities, including diabetes (52%), hypertension (76%), hy-
percholesterolaemia (43.5%), ischaemic heart disease (30%), per-
cutaneous coronary intervention (12%), coronary surgery (6%),
previous stroke (22%), carotid revascularisation (2.4%) and aortic
aneurysm (6%), and included current smokers (32%) and previ-
ous smokers (46%).
Doctors with no specialist training performed ABImeasurements,
and researchers conducted the study in a hospital catheterisa-
tion laboratory in Spain. Investigators performed manual doppler
ABI by using an 8 MHz doppler probe (Dopplex II MD2/SD,
ArjoHuntleigh Inc., Addison, Illinois) model and a sphygmo-
manometer with cuffs of appropriate size. They obtained auto-
matedABImeasurements by using automated oscillometric equip-
ment: OmronM4-1 (OmronHealthcare Europe BV, Hoofddorp,
TheNetherlands). The threshold for a positive test result was a sig-
nificant lesion of > 50% occlusion detected by catheter angiogra-
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phy (the reference standard). Researchers defined non-significant
PAD as < 50% obstruction.
According toVega 2011, the reported accuracy of automated oscil-
lometric ABI was not statistically significantly different from that
of the manual doppler method, with reported sensitivity of 97%
(95% confidence interval (CI) 93% to 99%) and specificity of
89% (95%CI 67% to 95%) for oscillometric ABI, compared with
sensitivity of 95% (95% CI 89% to 97%) and specificity of 56%
(95% CI 33% to 70%) for the manual doppler ABI. The reason
for the lower specificity for the doppler was that the doppler could
not detect a tibial or dorsalis pedis pulse in 12 legs with normal
vessels or non-significant lesions, among a total of 27 legs. How-
ever, with the automated method, investigators could not measure
blood pressure in 70 legs, 69 of which were found to have severe
angiographic lesions. The superiority of the automated oscillomet-
ric method for obtaining an ABI reading over the manual method
in which inexperienced operators used a doppler probe may be a
clinically important finding.
Researchers reported accuracy estimates with ’limbs’ as the unit
of analysis, and as participant-level data are not available, we were
unable to reproduce accuracy estimates. The number of significant
lesions (occlusions > 50%) detected by angiography in this study
population was 131 (83%).
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Summary of findings
Accuracy of the ankle brachial index (ABI) in diagnosing symptomatic peripheral arterial disease (PAD)
Population: People with interm it tent claudicat ion
Setting Primary and secondary care sett ings (hospital outpat ients)
Index test Ankle brachial index
Importance The success of management strategies for PAD depends upon the quality of the diagnost ic process, which involves careful assessment of
the underlying pathology with diagnost ic tests that possess a high level of accuracy, to allow detect ion and measurement of an arterial
stenosis and its distribut ion in the blood vessels
Reference standard Duplex ultrasonography or angiography
Studies Cross-sect ional or diagnost ic cohort study
Test/ subgroup Sensitivity Specificity No. of participants (studies) Quality (QUADAS-2)a and comments
Cut-of f ABI rat io posit ivity
M ild PAD:
0.7 to 0.9
Moderate PAD:
0.41 to 0.69
Automated ABI:
Manual ABI:
97% (95%CI 93% to 99%)
95% (95%CI 89% to 97%)
89% (95%CI 67% to 95%)
56% (95%CI 33% to 70%)
85 (n = 158 legs) (1 study) Unclear risk of bias: Vega 2011 may
have included pat ients with severe
PAD (stenosis > 50%); the threshold
was not reported; t ime between con-
duct of the index test and use of the
reference standard is not reported
One study, no pooled analysis, sen-
sit ivity and specif icity data for limb
level - not for part icipant level, as re-
ported by study authors
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aQUADAS-2 is a tool used for assessment of the quality of diagnost ic accuracy studies. This tool comprises four domains:
pat ient select ion, index test, reference standard and f low and tim ing. Each domain is assessed in terms of risk of bias; the
f irst three domains are also assessed in terms of concerns regarding applicability.
ABI: ankle brachial index.
PAD: peripheral arterial disease.
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D I S C U S S I O N
The ankle brachial index (ABI) test is cheap and non-invasive,
which makes it potentially valuable in health care. Unfortunately,
evidence for the accuracy of the ABI test for the detection of
peripheral arterial disease (PAD) in people presentingwith leg pain
on exercise that is alleviated by rest is sparse. We included in this
review only one study, which evaluated automated versus manual
ABI equipment, and provided limb-level data from a total of 85
participants.
The main findings of the review are the following: (1) Although
both ABI tests demonstrated high levels of sensitivity, the results
came from a single small study in which participants with critical
limb ischaemia (CLI) may have been included, and researchers
reported no threshold for the ABI; (2) investigators reported no
statistically significant differences in accuracy between automated
and manual ABI equipment in this small group of participants,
although automated ABI was associated with a greater number of
technical failures than the hand-held doppler, and these technical
failures occurred in participants with severe angiographic lesions;
and (3) in light of recruitment of patients from those already re-
ferred for angiography, it seems likely that participants included in
the review may have had worse PAD than those recruited directly
from a primary healthcare setting, and we would not extrapolate
these findings to all patients presenting in primary care.
More than half of the participants in this study had received a
diagnosis of diabetes mellitus, but we were unable to produce
evidence to support the advice given in clinical guidelines (NICE
2012) that the use of ABI in assessment of PADamong people with
diabetes is less reliable than among those who do not have diabetes
mellitus, because data were not available for such an analysis. The
single included study (Vega 2011) excluded patients with an ABI
> 1.4, but investigators excluded only two patients for this reason
and did not reveal whether these patients had diabetes.
The review excluded 48 studies, most of which were cross-sec-
tional studies evaluating the accuracy of ABI or comparing differ-
ent ABI techniques in the diagnosis of PAD. Unfortunately, these
studies usually included patients other than those presenting with
exertional leg pain, and many did not use the reference standard of
duplex ultrasonography or angiography. These shortcomings are
important findings of this review, and in the recommendations for
research section below, we make specific suggestions to inform the
design of future DTA studies of ABI for the diagnosis of PAD in
people with exertional leg pain.
Summary of main results
This review found a very small amount of evidence indicating
that the ABI test is accurate in the diagnosis of symptomatic PAD
among people with intermittent claudication (IC). The one in-
cluded study suggests that automated equipment may be more
accurate than manual methods when used by individuals with no
specialist training. The accuracy of manual doppler varies with
operator skill, and so trained individuals may obtain more accu-
rate results with this method. The small number of participants
who took part in the study led to our cautious interpretation of
the data.
Strengths and weaknesses of the review
We identified only one study for inclusion. We restricted the in-
clusion criteria for this review to patients with leg pain on walking
relieved by rest and use of duplex ultrasonography or angiography
as the reference standard; this contributed to the exclusion of a
large number of studies.
Vega 2011 included some patients with ’suspected advanced PAD’
and did not present data for these participants separately. Thismay
have led to higher estimates of accuracy than would be observed
in a population that was strictly recruited on the basis of leg pain
alone. In addition, researchers did not report the ABI threshold.
Vega 2011 reported accuracy data at limb level only; therefore we
were unable to calculate estimates of sensitivity and specificity for
individual participants.We attempted to contact the study authors
to obtain participant-level data, but we received no response.
Applicability of findings to the review question
The patient population recruited to the included study suggests
that the findingsmay not answer the review question. Investigators
recruited the study population from patients referred for angiogra-
phy for peripheral arterial intermittent claudication or suspected
advanced PAD (Vega 2011). The percentage of people with symp-
toms of IC and the percentage with more advanced PAD remain
unclear, but it is likely that researchers included in this popula-
tion people with critical limb ischaemia. Use of angiography as the
reference standard by which to verify results of the ABI (index)
test may mean that the spectrum of disease is worse than in the
general population seeking a diagnosis for PAD, as angiography is
an invasive test conducted in hospital vascular departments. Au-
thors of the included study themselves cautioned that their find-
ings should not be extrapolated to the general population because
of the high prevalence of PAD reported among study participants
(Vega 2011).
Authors of another systematic review evaluating the accuracy of
ABI for PAD suggest that accuracy is dependent on the purpose of
the examination; they found ABI to be highly accurate when used
to detect serious stenosis (> 50%) (Dachun 2013). The American
Heart Association (AHA) Scientific Statement on measurement
and interpretation of the ABI reports that areas under the receiver
operating characteristic (ROC) curve are higher for ABI measured
by doppler than for ABI measured by oscillometric methods (
Aboyans 2012). This narrative review provides evidence on the
overall diagnostic ability of the ABI in a variety of populations
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and settings based on four studies that did not meet the eligibility
criteria for the current review (Aboyans 2012).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review found little evidence on the value of the ankle brachial
index (ABI) for detection of lower limb peripheral arterial disease
(PAD) in patients with exertional leg pain. The paucity of studies
assessing the accuracy of ABI in patients with leg pain and the
small number of participants enrolled in only one included study
mean that robust conclusions cannot be reached.
It is oftenwritten that the ABI is not a useful test for detecting PAD
in those with diabetes (Bhasin 2007; MacLeod-Roberts 1995) be-
cause incompressibility of calcified vessels produces false results.
In the included study, the co-morbidities of participants who were
withdrawn, or in whom ABI measurement was not possible, are
not reported, and uncertainty exists about the influence that any
underlying disease may have on the accuracy of ABI in the diag-
nosis of PAD.
Implications for research
Well-designed primary studies are needed to evaluate the diagnos-
tic accuracy of ABI in patients presenting specifically with exer-
tional leg pain in both primary and secondary (outpatient) health-
care settings. Further systematic review of existing studies assess-
ing the use of ABI in alternative patient groups, including high-
risk patients without leg pain and patients with atypical leg pain,
is required. Additional primary studies will likely be required in
these populations, including patients not previously diagnosed
with PAD and asymptomatic patients with co-morbidities such as
diabetes mellitus.
We suggest that duplex ultrasonography is a more appropriate
reference standard for a population of patients who present for
assessment for the first time, as it is non-invasive in nature andmay
be available outside the hospital setting. We recommend that this
single reference standard should be used to validate the presence or
absence of disease in the ABI test result for each individual patient.
A comparison of the accuracy between the manual doppler probe
ABI and automated oscillometric ABI measurements has cost im-
plications, deserves further consideration, and should include pa-
tients with co-morbidities such as diabetes mellitus and should be
performed by trained healthcare professionals.
Moreover, study authors must be careful about how they analyse
their data, in particular, they need to account for participants
contributing data from both legs and must provide participant-
level data to facilitate meta-analyses in updates of this, and other,
systematic reviews.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Vega 2011
Study characteristics
Patient sampling The sample of patients was reported to be consecutive.
Patient characteristics and set-
ting
85 patients (158 legs) referred to the catheterisation laboratory for angiography for peripheral arterial
intermittent claudication or suspected advanced PAD and over 30 years of age were included
Index tests Doppler ABI measurement was performed with an 8 MHz doppler probe (Dopplex II MD2/SD,
Huntleigh model) (ArjoHuntleigh Inc., Addison, Illinois), and a sphygmomanometry with cuffs
of appropriate size. The oscillometer used was an Omron M4-1 (Omron Healthcare Europe BV,
Hoofddorp, The Netherlands). The ABI was calculated as the ratio of peak systolic pressure at
the ankle and arms. Patients with non-compressible arteries with ABI > 1.4 were excluded. If the
oscillometric method still gave an error reading after 3 serial attempts with rehabilitation of cuff
pressures, pressure was assumed to be < 60 mmHg and a ’0 index’ was assigned if it was not possible
to detect flow with the doppler method (DM)
The ABI threshold was not prospectively stated.
Target condition and reference
standard(s)
Haemodynamically significant or severe PAD was defined as stenosis with > 50% obstruction, and
non-significant PAD as < 50% obstruction. Severity was determined simultaneously by visual com-
parison between healthy and diseased segments and by use of the Quantitiative Coronary Angiog-
raphy (QCA) programme. Reference standard was the angiography digital subtraction technique
with sequential images
Flow and timing We excluded 12 legs for a variety of reasons: 6 cases because of amputation, 4 because of painful
ulcers, which ruled out examination, and 2 because ABI was > 1.4
The time between the conduct of the index test and use of the reference standard is not reported
Comparative
Notes Only 131 (83%) limbs had verification from angiography. Contacted study author to request
participant-level data and received no response
Methodological quality
Item Authors’ judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random
sample of patients enrolled?
Yes
Was a case-control design
avoided?
Yes
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Vega 2011 (Continued)
Did the study avoid inappropri-
ate exclusions?
Unclear
Unclear Unclear
DOMAIN 2: Index Test ABI
If a threshold was used, was it
pre-specified?
No
Unclear Unclear
DOMAIN 3: Reference Standard
Is the reference standards likely
to correctly classify the target
condition?
Yes
Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate inter-
val between index test and ref-
erence standard?
Unclear
Were all patients included in the
analysis?
No
Unclear
ABI: ankle brachial index.
DM: doppler method.
PAD: peripheral arterial disease.
QCA: quantitative coronary angiography.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Akhtar 2009 Study did not use duplex ultrasonography nor angiography as reference standard. Case-control study com-
paring different techniques for measurement of the ABI (hand-held doppler ABI vs palpatory ABI) in healthy,
high-risk asymptomatic and known PAD patients
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(Continued)
Alnaeb 2007 Study population not defined as presenting with exertional leg pain. Patients with diabetes, recruited from
hospital vascular clinic, and control patients from an orthopaedic outpatient clinic used to compare ABI and
photoplethysmography with duplex ultrasonography
Alnaeb 2008 Study population not defined as presenting with exertional leg pain. PAD and non-PAD patients recruited
from vascular outpatient clinic for comparison of ABI and photoplethysmography with duplex ultrasonog-
raphy
Armstrong 2010 Study did not use duplex ultrasonography nor angiography as reference standard. Study comparing physical
examination with ABI in people suspected of having or at high risk for PAD
Baxter 1993 Study population not selected owing to exertional leg pain. Patients with lower limb claudication, rest pain or
cellulitis assessed with ABI, colour doppler ultrasonography and arteriography. Separate data for claudication
population sought from study author, who replied that data were not available
Beckman 2005 Study did not use duplex ultrasonography nor angiography as reference standard. Comparison of 2 different
types of ABI (oscillometric and continuous wave doppler ultrasonography) in participants referred to lab for
evaluation of PAD
Benchimol 2009 Study did not use duplex ultrasonography nor angiography as reference standard. Comparison of ABI mea-
suring methods (automated vs doppler ultrasonography) in participants recruited by physicians in preventive
medicine attending annual check-up
Beutner 2012 Study did not use duplex ultrasonography nor angiography as reference standard. Study compared 2 different
ABImeasurement methods in healthy participants and in participants with confirmed lower limb PAD before
revascularisation
Bogomolov 2012 Study did not use duplex ultrasonography nor angiography as reference standard. Unclear whether study
population was selected for exertional leg pain. Study performed ABI and doppler examination in people
with and without diabetes
Cacoub 2005 Comparison of 2 types of ABI measurements (stethoflux and continuous wave doppler) in patients recruited
consecutively from vascular laboratory
Carmo 2009 Study did not use duplex ultrasonography nor angiography as reference standard. Comparison of ABI mea-
sured by stethoscope and doppler in people referred to haemodynamic laboratory of Fekicio Rocho Hospital
for peripheral, renal, coronary and cerebral vascular territory diagnostic and interventional angiographic ex-
aminations
Clairotte 2009 Unclear whether study population selected because of exertional leg pain. Study assessed oscillometric ABI
vs doppler ABI in patients referred to physiology department for doppler ultrasound examination of PAD.
Two-dimensional ultrasound measurement reported but not used as reference standard
Cortez-Cooper 2003 Study did not use duplex ultrasonography nor angiography as reference standard. Study compared automated
device with manual method for assessment of ABI in normotensive and hypertensive participants
Eason 2005 Study did not use duplex ultrasonography nor angiography as reference standard. Study in asymptomatic
PAD population (patients with symptomatic PAD were excluded). PAD assessed via ABI and the San Diego
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(Continued)
claudication questionnaire
Ena 2011 Study did not use duplex ultrasonography nor angiography as reference standard. Study compared ABI
measured with upper arm automated blood pressure device vs ABI measured by hand-held doppler in diabetic
patients attending screening for PAD
Espeland 2008 Study did not use duplex ultrasonography nor angiography as reference standard. Population not presenting
with exertional leg pain. Study compared different systolic blood pressure protocols for measuring ABI in a
trial population of overweight/obese volunteers with type 2 diabetes
Feigelson 1994 Study population not identified as presenting with exertional leg pain. Participants were a population-based
cohort of adults screened for large-vessel PAD
Fronek 1999 Index test was upper thigh/brachial index measurement rather than ankle/brachial index measurement. Study
performed in patients referred to the Veterans’ Administration Vascular Laboratory with suspected arterial
occlusive disease of lower extremities
Guo 2008 Populationnot identified as presentingwith exertional leg pain to primary care or outpatient clinic. Participants
recruited from cardiology hospital ward
Heidrich 1998 Index test involved measurement of BP in upper limb digital arteries. Study population consisted of people
with primary or secondary Raynaud’s disease or digital occlusions
Hoyer 2012 Index test was new portable photoplethysmography device for diagnosing ABI; reference standard was strain-
gauge plethysmography
Hriljac 2004 Study didnot report the use of duplex ultrasonography nor angiography as reference standard.Unclearwhether
study population referred for exertional leg pain, Study assessed the added diagnostic utility of measuring
ABI and pulse volume waveforms at rest and after exercise in patients referred to vascular laboratory by ’non-
vascular’ specialists
Johansson 2002 Study did not use duplex ultrasonography nor angiography as reference standard. Population not identified
as presenting with exertional leg pain. Study compared pulse oximetric method for assessment of toe pressure
ABI with traditional ankle doppler pressure ABI in people with diabetes drawn from the case records of
primary healthcare clinics
Klein 2003 Study population not identified as presenting with exertional leg pain. Participants were patients considered
for fibula free flap transplantation or those who had undergone this procedure. Patients with a history of
intermittent claudication were excluded
Kollias 2011 Study did not use duplex ultrasonography nor angiography as reference standard. Study investigated auto-
mated vs manual doppler method in patients with CVD risk factors attending hypertension or diabetes clinic
Korno 2009 Study did not use duplex ultrasonography nor angiography as reference standard. Study compared automated
oscillometric ABI vs hand-held doppler ABI in patients admitted for surgical treatment or for evaluation of
venous disease to the department of vascular surgery, including participants with intermittent claudication
or critical ischaemia
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Kurtoglu 2009 Study populationnot identified as presentingwith exertional leg pain. Participantswere patientswith extremity
injury or with suspicion of peripheral artery injury admitted to trauma and emergency medicine department
Lijmer 1996 Patients referred by general practitioner for claudication or critical ischaemia - separate ABI data for patients
with IC requested from study authors but no reply received
MacDougall 2008 Study did not use duplex ultrasonography nor angiography as reference standard. Study investigated oscil-
lometric ABI vs doppler ABI in 3 groups of patients: normal volunteers, patients with significant CV risk
profiles and patients suspected of having PAD who were referred to a vascular lab
Manzano 2006 Study did not use duplex ultrasonography nor angiography as reference standard. Study population was
not defined as people presenting with exertional leg pain. Study compared ABI vs Edinburgh Claudication
Questionnaire in patients without typical intermittent claudication or known atherosclerotic disease
McLafferty 1997 Study population consisted of people who had undergone previous revascularisation procedures
Mehlsen 2008 Paper reports 2 studies, neither of which used duplex ultrasonography nor angiography as reference standard
• Study compared measurement of blood pressures at ankle and toe levels with oscillometry with
mercury strain gauge plethysmography in patients with possible PAD referred to vascular unit
• Study compared low ABI measurement using oscillometry with mercury strain gauge plethysmography
in patients attending primary care clinics for any reason
Nam 2010 Index test was ABI measured using photoplethysmography (currently not an endorsed method for the assess-
ment of ABI)
Nexoe 2012 Study did not use duplex ultrasonography nor angiography as reference standard. Study compared ABI
measured in GP surgery vs ABI measured by experienced staff of Department of Nuclear Medicine in people
presenting to GP surgery
Niazi 2006 Uncertain whether study population was recruited with exertional leg pain. Population recruited from a
retrospective sample of people who had undergone an angiogram and ABI measurement; no indication for
angiography given. Study authors contacted for further information but did not reply
Oksala 2010 Study did not use duplex ultrasonography nor angiography as reference standard. Study compared different
methods of calculating ABI from BP measurements in people 50 to 69 years of age with ≥ 1 cardiovascular
risk factor; > 70 years of age; with claudication defined as pain in the calf during exercise
Paez 2010 Study population was not defined as presenting with exertional leg pain. Patients with ≥ 1 cardiovascular risk
factor were recruited from the Heart Institute of Bucaramanga (Colombia)
Parmeswarin 2005 Study did not use duplex ultrasonography nor angiography as reference standard. Study compared ABI
with pulse oximetry test in patients with type 2 diabetes without known lower extremity arterial disease or
symptoms of LEAD (typical IC or rest pain)
Potier 2008 Study did not use duplex ultrasonography nor angiography as reference standard. Study compared doppler
ABI and oscillometric measured ABI in diabetic and non-diabetic patients
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(Continued)
Premalatha 2002 Study population was not defined as presenting with exertional leg pain. Participants were diabetic hospital
inpatients with severe foot infection
Premanath 2010 Study did not use duplex ultrasonography nor angiography as reference standard. Study population was not
defined as presenting with exertional leg pain. Study compared differentmethods ofmeasuring ABI in patients
with diabetes attending a clinic, irrespective of their symptoms
Ramos 2011 Study did not use duplex ultrasonography nor angiography as reference standard. Study population was not
defined as presenting with exertional leg pain. Study used ABI < 0.9 as an outcome to develop a predictive
risk score for low ABI in people recruited from a primary healthcare setting, irrespective of symptoms
Schroder 2006 Study population was not defined as presenting with exertional leg pain. Participants were patients presenting
at outpatient clinic with suspected vascular disease; < 40% had intermittent claudication (data not presented
separately in paper, and study authors unable to provide data when contacted)
Stoffers 1996 Unclear whether duplex ultrasonography or angiography was used as reference standard. Participants selected
from Limburg POAD study with ABI < 0.95, typical IC complaints or leg complaints less typical of IC but
with ≥ 1 foot pulse missing, Study compared ABI measurements with diagnostic conclusions of vascular
laboratory from “sophisticated ultrasound measurements”. Pressure measurements at rest and after treadmill
walking test; technician interpreted acoustic and audiospectrum pulsewave signals from posterior tibial and
dorsalis pedis arteries. No separate 2 × 2 data for the 22 patients in the total population who had IC. Contacted
study author, who replied that data were not available
Vinyoles 2007 Study did not use duplex ultrasonography nor angiography as reference standard. Study population was
not defined as presenting with exertional leg pain. Study compared oscillometry ABI vs ABI measured with
doppler ultrasound probe
Williams 2005 Study population was not defined as presenting with exertional leg pain. Study evaluated ABI and other
methods of screening for lower limb PAD in diabetic and non-diabetic participants with and without arterial
disease and neuropathy
Wohlfahrt 2011 Study did not use duplex ultrasonography nor angiography as reference standard. Study population was not
defined as presenting with exertional leg pain. Study compared doppler ABI vs oscillometric ABI in randomly
selected general population sample
Zhang 2010 Study population was not defined as presenting with exertional leg pain. Study assessed lower limb PAD using
ABI and duplex ultrasonography in diabetic individuals recruited from a secondary care setting, irrespective
of symptoms
ABI: ankle brachial index.
CV: cardiovascular.
DTA: diagnostic test accuracy.
IC: intermittent claudication.
PAD: peripheral arterial disease.
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D A T A
This review has no data.
A P P E N D I C E S
Appendix 1. MEDLINE search strategy
Database: Ovid MEDLINE(R) <1946 to July Week 5 2013>
Search Strategy:
--------------------------------------------------------------------------------
1 Ankle Brachial Index/ (1231)
2 Oscillometry/ [Methods] (1841)
3 Blood Pressure Determination/ (16515)
4 Laser-Doppler Flowmetry/ (7317)
5 oscillometr$.ti,ab. (1745)
6 (doppler adj2 (ultrasound or flow$ or method or device)).ti,ab. (24957)
7 ABI.ti,ab. (4022)
8 ABPI.ti,ab. (309)
9 AAI.ti,ab. (1016)
10 (ankle adj4 index).ti,ab. (3997)
11 (arm adj4 index).ti,ab. (877)
12 (brachial adj4 (index or pressure)).ti,ab. (4836)
13 (systolic adj5 ratio).ti,ab. (2833)
14 (pressure adj5 ratio).ti,ab. (5088)
15 (BP adj5 ratio).ti,ab. (618)
16 (four and limbs and pressure).ti,ab. (309)
17 or/1-16 (63464)
18 (anterior tibial or dorsalis pedis or posterior tibial).ti,ab. (6189)
19 (ankle or arm or elbow or calf ).ti,ab. (172149)
20 (lower and upper and (extremit$ or limb)).ti,ab. (9791)
21 or/18-20 (185143)
22 (systolic or pressure).ti,ab. (588700)
23 21 and 22 (11891)
24 17 or 23 (71623)
25 exp Peripheral Vascular Diseases/di [Diagnosis] (8148)
26 Arterial Occlusive Diseases/di [Diagnosis] (4178)
27 exp Arteriosclerosis/di [Diagnosis] (13998)
28 exp Atherosclerosis/di [Diagnosis] (2178)
29 exp Peripheral Arterial Disease/di [Diagnosis] (498)
30 Intermittent Claudication/di [Diagnosis] (994)
31 (atherosclero* or arteriosclero* or PVD or PAOD or PAD).ti,ab. (130870)
32 (arter$ adj4 ($occlus$ or steno$ or obstruct$ or lesio$ or block$ or obliter$)).ti,ab. (76067)
33 (vascular adj4 (occlus* or steno* or obstruct* or lesio* or block* or obliter*)).ti,ab. (20139)
34 (vein* adj4 (occlus* or steno* or obstruct* or lesio* or block* or obliter*)).ti,ab. (8880)
35 (veno* adj4 (occlus* or steno* or obstruct* or lesio* or block* or obliter*)).ti,ab. (9793)
36 (peripher* adj4 (occlus* or steno* or obstruct* or lesio* or block* or obliter*)).ti,ab. (12782)
37 (peripheral adj3 dis*).ti,ab. (28626)
38 arteriopathic.ti,ab. (152)
39 (claudic* or hinken* or IC).ti,ab. (53144)
25Ankle brachial index for the diagnosis of lower limb peripheral arterial disease (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
40 CLI.ti,ab. (1175)
41 dysvascular*.ti,ab. (144)
42 (leg adj4 (obstruct* or occlus* or steno* or block* or obliter*)).ti,ab. (484)
43 (limb adj4 (obstruct* or occlus* or steno* or block* or obliter*)).ti,ab. (1330)
44 (lower adj3 extrem* adj4 (obstruct* or occlus* or steno* or block* or obliter*)).ti,ab. (1345)
45 or/25-44 (320767)
46 24 and 45 (10229)
Appendix 2. Embase search strategy
Database: Embase <1980 to 2013 Week 32>
Search Strategy:
--------------------------------------------------------------------------------
1 ankle brachial index/ (4434)
2 oscillometry/ (6310)
3 blood pressure measurement/ (34214)
4 laser Doppler flowmetry/ (8539)
5 oscillometr$.ti,ab. (2398)
6 (doppler adj2 (ultrasound or flow$ or method or device)).ti,ab. (31994)
7 ABI.ti,ab. (6940)
8 ABPI.ti,ab. (455)
9 AAI.ti,ab. (1452)
10 (ankle adj4 index).ti,ab. (5541)
11 (arm adj4 index).ti,ab. (1137)
12 (brachial adj4 (index or pressure)).ti,ab. (6690)
13 (systolic adj5 ratio).ti,ab. (3654)
14 (pressure adj5 ratio).ti,ab. (6524)
15 (BP adj5 ratio).ti,ab. (895)
16 (four and limbs and pressure).ti,ab. (389)
17 or/1-16 (98837)
18 (anterior tibial or dorsalis pedis or posterior tibial).ti,ab. (7231)
19 (ankle or arm or elbow or calf ).ti,ab. (210874)
20 (lower and upper and (extremit$ or limb)).ti,ab. (14215)
21 or/18-20 (228282)
22 (systolic or pressure).ti,ab. (736050)
23 21 and 22 (15587)
24 17 or 23 (109336)
25 peripheral vascular disease/di [Diagnosis] (2054)
26 artery disease/di [Diagnosis] (1691)
27 arteriolosclerosis/di [Diagnosis] (32)
28 arteriosclerosis/di [Diagnosis] (2186)
29 atherosclerosis/di [Diagnosis] (5485)
30 atherosclerotic plaque/di [Diagnosis] (2755)
31 peripheral occlusive artery disease/di [Diagnosis] (3610)
32 artery occlusion/di [Diagnosis] (2700)
33 intermittent claudication/di [Diagnosis] (870)
34 (atherosclero* or arteriosclero* or PVD or PAOD or PAD).ti,ab. (168115)
35 (arter$ adj4 ($occlus$ or steno$ or obstruct$ or lesio$ or block$ or obliter$)).ti,ab. (96829)
36 (vascular adj4 (occlus* or steno* or obstruct* or lesio* or block* or obliter*)).ti,ab. (25100)
37 (vein* adj4 (occlus* or steno* or obstruct* or lesio* or block* or obliter*)).ti,ab. (11516)
38 (veno* adj4 (occlus* or steno* or obstruct* or lesio* or block* or obliter*)).ti,ab. (11947)
39 (peripher* adj4 (occlus* or steno* or obstruct* or lesio* or block* or obliter*)).ti,ab. (16599)
40 (peripheral adj3 dis*).ti,ab. (37189)
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41 arteriopathic.ti,ab. (183)
42 (claudic* or hinken* or IC).ti,ab. (43148)
43 CLI.ti,ab. (1795)
44 dysvascular*.ti,ab. (165)
45 (leg adj4 (obstruct* or occlus* or steno* or block* or obliter*)).ti,ab. (585)
46 (limb adj4 (obstruct* or occlus* or steno* or block* or obliter*)).ti,ab. (1808)
47 (lower adj3 extrem* adj4 (obstruct* or occlus* or steno* or block* or obliter*)).ti,ab. (1656)
48 or/25-47 (372990)
49 24 and 48 (14665)
Appendix 3. CINAHL search strategy
S40 S22 AND S39 1,666
S39 S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR
S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR
S37 OR S38 OR S39
44,201
S38 TI ( (limb N4 (obstruct* or occlus* or steno* or block* or
obliter*)) ) OR AB ( (limb N4 (obstruct* or occlus* or steno*
or block* or obliter*)) )
159
S37 TI ( (leg N4 (obstruct* or occlus* or steno* or block* or
obliter*)) ) OR AB ( (leg N4 (obstruct* or occlus* or steno*
or block* or obliter*)) )
70
S36 TI dysvascular* OR AB dysvascular 75
S35 TI CLI OR AB CLI 123
S34 TI ( claudic* or hinken* or IC ) OR AB ( claudic* or hinken*
or IC )
3,907
S33 TI arteriopathic OR AB arteriopathic 9
S32 TI peripheral N3 dis* OR AB peripheral N3 dis* 4,086
S31 TI ( (peripher* N4 (occlus* or steno* or obstruct* or lesio*
or block* or obliter*)) ) OR AB ( (peripher* N4 (occlus* or
steno* or obstruct* or lesio* or block* or obliter*)) )
1,159
S30 TI ( (veno* N4 (occlus* or steno* or obstruct* or lesio* or
block* or obliter*)) ) OR AB ( (veno* N4 (occlus* or steno*
or obstruct* or lesio* or block* or obliter*)) )
656
S29 TI ( (vein* N4 (occlus* or steno* or obstruct* or lesio* or
block* or obliter*)) ) OR AB ( (vein* N4 (occlus* or steno* or
obstruct* or lesio* or block* or obliter*)) )
696
27Ankle brachial index for the diagnosis of lower limb peripheral arterial disease (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
S28 TI ( (vascular N4 (occlus* or steno* or obstruct* or lesio* or
block* or obliter*)) ) OR AB ( (vascular N4 (occlus* or steno*
or obstruct* or lesio* or block* or obliter*)) )
1,251
S27 TI ( (arter* N4 (occlus* or steno* or obstruct* or lesio* or
block* or obliter*)) ) OR AB ( (arter* N4 (occlus* or steno*
or obstruct* or lesio* or block* or obliter*)) )
6,063
S26 TI ( atherosclero* or arteriosclero* or PVD or PAOD or PAD
) OR AB ( atherosclero* or arteriosclero* or PVD or PAOD
or PAD )
11,796
S25 (MH“Atherosclerosis”)OR (MH“IntermittentClaudication/
DI”)
3,829
S24 (MH “Arterial Occlusive Diseases+”) OR (MH “Arterioscle-
rosis+/DI”)
24,816
S23 (MH “Peripheral Vascular Diseases+/DI”) 1,760
S22 S15 OR S21 12,571
S21 S19 AND S20 2,069
S20 TI ( systolic or pressure ) OR AB ( systolic or pressure ) 69,646
S19 S16 OR S17 OR S18 31,950
S18 TI ( (lower and upper and (extremit* or limb)) ) OR AB (
(lower and upper and (extremit* or limb)) )
2,062
S17 TI ( ankle or arm or elbow or calf ) OR AB ( ankle or arm or
elbow or calf )
28,839
S16 TI ( anterior tibial or dorsalis pedis or posterior tibial ) OR
AB ( anterior tibial or dorsalis pedis or posterior tibial )
1,839
S15 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR
S9 OR S10 OR S11 OR S12 OR S13 OR S14
11,160
S14 TI ( four and limbs and pressure ) OR AB ( four and limbs
and pressure )
23
S13 TI BP N5 ratio OR AB BP N5 ratio 105
S12 TI pressure N5 ratio OR AB pressure N5 ratio 653
S11 TI systolic N5 ratio OR AB systolic N5 ratio 340
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S10 TI ( (brachial N4 (index or pressure)) ) OR AB ( (brachial N4
(index or pressure)) )
953
S9 TI arm N4 index OR AB arm N4 index 210
S8 TI ankle N4 index OR AB ankle N4 index 871
S7 TI AAI OR AB AAI 236
S6 TI ABPI OR AB ABPI 83
S5 TI ABI OR AB ABI 743
S4 TI ( (doppler N2 (ultrasound or flow* or method or device)
) ) OR AB ( (doppler N2 (ultrasound or flow* or method or
device)) )
2,041
S3 TI oscillometr* OR AB oscillometr* 337
S2 MH Blood Pressure Determination 5,576
S1 MH Ankle Brachial Index 1,194
Appendix 4. LILACS search strategy
Database : LILACS 13 August 2013
http://bases.bireme.br/cgi-bin/wxislind.exe/iah/online/
Search on : ((ankle OR arm or brachial) AND index) OR ((ultrasound OR flow$ OR method OR device) AND
doppler) OR abi OR abpi OR aai [Words] and atherosclero$ OR arteriosclero$ OR pvd OR paod OR
pad OR cli OR ((occlus$ OR steno$ OR obstruct$ OR lesion$ OR block$ OR obliter$) and leg or
limb) OR claudic$ [Words] or (ankle brachial index orOscillometry or Blood Pressure Determination or
Laser-Doppler Flowmetry) AND (Atherosclerosis OR (Peripheral Arterial Disease)) [Subject descriptor]
Total of references : 176
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Appendix 5. DARE (Database of Abstracts of Reviews of Effects) and the Health Technology
Assessment Database (HTA) in The Cochrane Library
#1 MeSH descriptor: [Arteriosclerosis] explode all trees and with
qualifiers: [Diagnosis - DI]
408
#2 MeSH descriptor: [Arteriolosclerosis] explode all trees and
with qualifiers: [Diagnosis - DI]
0
#3 MeSH descriptor: [Arteriosclerosis Obliterans] explode all
trees and with qualifiers: [Diagnosis - DI]
3
#4 MeSH descriptor: [Atherosclerosis] explode all trees and with
qualifiers: [Diagnosis - DI]
45
#5 MeSH descriptor: [Arterial Occlusive Diseases] explode all
trees and with qualifiers: [Diagnosis - DI]
563
#6 MeSHdescriptor: [IntermittentClaudication] explode all trees
and with qualifiers: [Diagnosis - DI]
44
#7 MeSH descriptor: [Ischemia] explode all trees and with qual-
ifiers: [Diagnosis - DI]
48
#8 MeSH descriptor: [Peripheral Vascular Diseases] explode all
trees and with qualifiers: [Diagnosis - DI]
254
#9 MeSH descriptor: [Vascular Diseases] explode all trees and
with qualifiers: [Diagnosis - DI]
4377
#10 MeSH descriptor: [Leg] explode all trees and with qualifiers:
[Blood supply - BS]
1090
#11 MeSH descriptor: [Femoral Artery] explode all trees 736
#12 MeSH descriptor: [Popliteal Artery] explode all trees 259
#13 MeSH descriptor: [Iliac Artery] explode all trees 152
#14 MeSH descriptor: [Tibial Arteries] explode all trees 29
#15 (atherosclero* or arteriosclero* or PVD or PAOD or PAD) 17613
#16 (arter*) near (*occlus* or steno* or obstruct* or lesio* or block*
or obliter*)
4961
#17 (vascular) near (*occlus* or steno* or obstruct* or lesio* or
block* or obliter*)
1416
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#18 (vein*) near (*occlus* or steno* or obstruct* or lesio* or block*
or obliter*)
747
#19 (veno*) near (*occlus* or steno* or obstruct* or lesio* or block*
or obliter*)
1004
#20 (peripher*) near (*occlus* or steno* or obstruct* or lesio* or
block* or obliter*)
1380
#21 peripheral near/3 dis* 3353
#22 arteriopathic 17
#23 (claudic* or hinken*) 1469
#24 (isch* or CLI) 17265
#25 dysvascular* 26
#26 leg near/4 (obstruct* or occlus* or steno* or block* or obliter*) 187
#27 limb near/4 (obstruct* or occlus* or steno* or block* or
obliter*)
241
#28 (lower near/3 extrem*) near/4 (obstruct* or occlus* or steno*
or block* or obliter*)
146
#29 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or
#11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #
19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27
or #28
42501
#30 MeSH descriptor: [Ankle Brachial Index] explode all trees 68
#31 MeSH descriptor: [Oscillometry] explode all trees and with
qualifiers: [Methods - MT]
31
#32 MeSH descriptor: [Blood Pressure Determination] this term
only and with qualifiers: [Methods - MT]
301
#33 MeSH descriptor: [Laser-Doppler Flowmetry] this term only
and with qualifiers: [Methods - MT]
63
#34 oscillometr*:ti,ab,kw (Word variations have been searched) 304
#35 (doppler near/2 (ultrasound or flow* or method or device)):ti,
ab,kw (Word variations have been searched)
2211
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#36 ABI or ABPI or AAI:ti,ab,kw (Word variations have been
searched)
321
#37 ankle near/4 index:ti,ab,kw (Word variations have been
searched)
458
#38 arm near/4 index:ti,ab,kw (Word variations have been
searched)
114
#39 (brachial near/4 (index or pressure)):ti,ab,kw (Word variations
have been searched)
847
#40 systolic near/5 ratio:ti,ab,kw (Word variations have been
searched)
247
#41 pressure near/5 ratio:ti,ab,kw (Word variations have been
searched)
505
#42 pressure near/5 ratio:ti,ab,kw (Word variations have been
searched)
505
#43 BP near/5 ratio:ti,ab,kw (Word variations have been searched) 71
#44 BP near/5 ratio:ti,ab,kw (Word variations have been searched) 71
#45 four and limbs and pressure:ti,ab,kw (Word variations have
been searched)
135
#46 #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37 or #
38 or #39 or #40 or #41 or #42 or #43 or #44 or #45
4577
#47 anterior tibial or “dorsalis pedis” or “posterior tibial”:ti,ab,kw
(Word variations have been searched)
226
#48 ankle or arm or elbow or calf:ti,ab,kw (Word variations have
been searched)
25464
#49 (lower and upper and (extremit* or limb)):ti,ab,kw (Word vari-
ations have been searched)
792
#50 #47 or #48 or #49 26142
#51 systolic or pressure:ti,ab,kw (Word variations have been
searched)
67765
#52 #50 and #51 2741
#53 #46 or #52 6726
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#54 #29 and #53 in Other Reviews and Technology Assessments 13
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Appendix 6. ISI Conference Proceedings Citation Index
Topic=(ABI or ABPI or AAI or (ankle NEAR/4 index) or (arm NEAR/4 index) or (brachial NEAR/4 (index or pressure)) or (systolic
NEAR/4 ratio) or (pressure NEAR/3 ratio) or (BP NEAR/3 ratio) or Oscillometr* or Blood Pressure Determination or Laser-Doppler
Flowmetry or (doppler NEAR/2 (ultrasound or flow* or method or device))) AND Topic=(Claudicat* or IC or CLI or atherosclero*
or arteriosclero* or PVD or PAOD or PAD or (arter* NEAR/4 (occlus* or steno* or obstruct* or lesio* or block* or obliter*)) or
(vascular NEAR/4 (occlus* or steno* or obstruct* or lesio* or block* or obliter*)) or (vein* NEAR/4 (occlus* or steno* or obstruct* or
lesio* or block* or obliter*)) or (veno* NEAR/4 (occlus* or steno* or obstruct* or lesio* or block* or obliter*)) or (peripher* NEAR/4
(occlus* or steno* or obstruct* or lesio* or block* or obliter*)) or (peripheral NEAR/3 dis*) or dysvascular* or (leg NEAR/4 (obstruct*
or occlus* or steno* or block* or obliter*)) or (limb NEAR/4 (obstruct* or occlus* or steno* or block* or obliter*)) or (lower NEAR/
4 (obstruct* or occlus* or steno* or block* or obliter*)))
Refined by: Document Types=( PROCEEDINGS PAPER ORMEETING ABSTRACT )
Timespan=All years. Databases=CPCI-S, CCR-EXPANDED, IC.
Results: 903
Appendix 7. ZETOC Conference search
ABI in title 87
ABPI in title 5
“brachial index” in title 14
Appendix 8. Medion search
ABI in title 36
ABPI in title 0
Brachial in title 2
Appendix 9. Quality Assessment Checklist (QUADAS-2)
Domains, signalling questions (SQ) and applicability Rating criteria
Domain 1: Patient selection
A. Risk of bias Describe the methods of patient selection given in the report:
SQ 1:
Was a consecutive or random sample of patients enrolled?
Yes: it is reported that a consecutive or a random sample was
included
Unclear: the precise method of sampling is not reported
SQ 2:
Did the study avoid inappropriate exclusions?
Yes: the study included all symptomatic outpatients (in primary
or secondary care) without previous ABI test results
No: the study included patients who had received an ABI test
before, or were asymptomatic
Unclear: the ABI test history of the patients in the study was not
reported
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(Continued)
B. Concerns regarding applicability Give the paper’s description of the inclusion/exclusion criteria,
including setting, prior tests and symptoms
Domain 2: Index test
A. Risk of bias Give the paper’s description of the index test and how it was con-
ducted and interpreted, including the background of the person
who carried out the test
SQ 1:
Were index test results interpreted without knowledge of results
of the reference standard?
Yes: it is stated that the index tests were interpreted in a blindman-
ner (i.e. without knowledge of results of the reference standard),
or the index test was always performed and interpreted before the
reference standard
No: the results of the reference standard were known to the reader
of the index test
Unclear: it is not reported whether the index test was conducted
without knowledge of results of the index test, or whether the
index test was completed before the reference standard
SQ 2:
If a threshold was used, was it prespecified?
Yes: value for an abnormal test result is < 0.90, and this is clearly
stated in the Methods section or elsewhere in the report
No: values for a normal or abnormal test results are not reported
(prespecified)
Unclear: it is not clear at what point in time values for normal
and abnormal test results were decided
SQ 3:
Was the person conducting the test (measuring the ABI) trained
to do so?
Yes: it is stated that the person conducting the test was trained in
ABI measurement
No: it is clearly reported that the person conducting the test was
not trained in ABI measurement
Unclear: the expertise and background of the individuals con-
ducting the index test are unclear
B. Concerns regarding applicability? High: the index test was conducted using hand-held Dopplers as
opposed to a stethoscope or other equipment not widely available
Low: the index test was not conducted using hand-heldDopplers,
and the equipment was standard (as outlined in the protocol)
Unclear: information about the equipment used to conduct the
test is not presented
Domain 3: Reference standard
A. Risk of bias Give the reported definition of the reference standard and how it
was conducted and interpreted
SQ 1:
Is the reference standard likely to correctly classify the target con-
dition?
Yes: it is reported that duplex ultrasonography or angiography test
results were interpreted by trained operatives
No: it is reported that the duplex ultrasonography or angiography
test results were not interpreted by trained operatives
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Unclear: it is not clear whether those individuals who inter-
preted the duplex ultrasonography or angiography test results were
trained
SQ 2:
Were the reference standard test results interpretedwithout knowl-
edge of the index test results?
Yes: the person classifying the reference standard test results was
unaware of the ABI test results
No: the person classifying the reference standard test results was
aware of the ABI test results
Unclear: not reported
SQ 3:
Was the person conducting the reference standard test (duplex
ultrasonography) trained?
Yes: it is stated that the person conducting the reference standard
test was trained in the interpretation of duplex ultrasonography
No: it is clear that the person conducting the reference standard
test was not trained in the interpretation of duplex ultrasonogra-
phy
Unclear: the expertise and background of the reference standard
test readers are unclear
Domain 4: Flow and timing
A. Risk of bias Describe the reasons why any patients recruited into the study
did not contribute to the 2 × 2 table (i.e. patients who did not
undergo the reference standard and/or the index test) referring to
the flow diagram
Give the time interval between the ABI and the reference standard
tests
SQ 1:
Was there an appropriate interval between the index test and the
reference standard?
Yes: the index and reference standard tests were all conducted
within 2 weeks of each other
No: some of the reference standard test results were not conducted
within 2 weeks of each other
Unclear: no information about the relative timing of the tests is
provided
SQ 2:
Did all the patients receive the same reference standard?
Yes: a complete set of reference standard test results is available
for all study patients
No: the same reference standard test results are not available for
all patients
Unclear: insufficient information is available tomake a judgement
about the availability of reference standard
SQ 3:
Were all patients included in the final analysis?
Yes: all patients enrolled contributed to the 2 × 2 table
No: not all patients enrolled contributed to the 2 × 2 table
Unclear: it is not clear whether patients were recruited but not
included in the study report of the 2 × 2 table
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C O N T R I B U T I O N S O F A U T H O R S
The whole review team has contributed to the development of the protocol. KW developed the search strategy. FC and AA applied the
eligibility criteria and extracted data from studies. FC completed RevMan. FMC assumed responsibility for plans for the analysis. All
review authors contributed to the final report of the review.
D E C L A R A T I O N S O F I N T E R E S T
FC: none known.
KW: none known.
AA: none known.
FMC: none known.
This review forms part of a National Institute of Health Research (NIHR) Cochrane programme grant (10/4001/14) and is being
conducted independently of our funders, the NIHR. The NIHR has had no input on the conduct or results of the review.
S O U R C E S O F S U P P O R T
Internal sources
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This project was supported by the NIHR, via Cochrane Programme Grant funding to Cochrane Vascular (10/4001/14). The views
and opinions expressed therein are those of the review authors and do not necessarily reflect those of the Systematic Reviews
Programme, NIHR, NHS or the Department of Health.
• Chief Scientist Office, Scottish Government Health Directorates, The Scottish Government, UK.
The Cochrane Vascular editorial base is supported by the Chief Scientist Office.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The reference standard in our protocol was duplex ultrasonography, and patients were required to have their peripheral arterial disease
(PAD) categorised as 1, 2 or 3 on the basis of the Rutherford index (Rutherford 1997), or as stage II on the basis of the Fontaine
classification system (Fontaine 1954). None of the studies that we considered for inclusion in the review met these criteria. After
discussion between the review authors and Cochrane Vascular editorial base, it was agreed that we should deviate from the protocol
to include studies that had used angiography as the reference standard and to include studies in which participants presented with
exertional leg pain, with or without subsequent categorisation by Fontaine 1954 or Rutherford 1997.
We were not able to search the Cochrane Register of Diagnostic Test Accuracy Studies.
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